Litcius/Paper detail

Neuroendocrine Tumor Theranostics: An Update and Emerging Applications in Clinical Practice

Sara Sheikhbahaei, Mohammad Salehi Sadaghiani, Steven P. Rowe, Lilja B. Sólnes

2021American Journal of Roentgenology20 citationsDOI

Abstract

Several studies support the safety and clinical efficacy of peptide receptor radionuclide therapies in disease control and quality-of-life improvement in patients with NETs and report potential benefits of combined radionuclide treatment approaches. The utility and pitfalls of functional imaging in therapy response assessment and surveillance of NETs remain to be established.

Topics & Concepts

MedicineROWENeuroendocrine tumorsClinical PracticeMedical physicsPathologyFamily medicineBusinessMarketingNeuroendocrine Tumor Research AdvancesLung Cancer Research StudiesNeuroblastoma Research and Treatments
Neuroendocrine Tumor Theranostics: An Update and Emerging Applications in Clinical Practice | Litcius